TYLENOL® Safety Profile
The safety of TYLENOL® at recommended doses, has been established over 50 years of use and scientific investigation. McNeil Consumer Healthcare has studied acetaminophen in over 1500 patients who received recommended daily doses (4 grams) for up to one year. Acetaminophen Case Study
Studies have shown that TYLENOL® (acetaminophen):
- Delivers a superior GI safety profile compared to Rx NSAIDs
- Does not interfere with antihypertensive therapy
- Does not interfere with aspirin heart therapy
Use in Medically Complex Patients
Even in complex patient cases, TYLENOL® remains a safe choice, when used as directed. Respected medical associations endorse acetaminophen as a first-line analgesia in these populations:
- The National Kidney Foundation, for episodic use in patients with underlying kidney disease
- The American Lung Association, for aches and pains associated with colds and flu
- The American Heart Association, for patients with known cardiovascular disease or risk factors for ischemic heart disease
- The American Geriatrics Society, for mild-to-moderate musculoskeletal pain in people ages 50 and over